$100 Gefitinib Film-Coated Tablets NSCLC EGFR Exon 19/21 Mutations

Gefitinib is an inhibitor that goes after certain EGFR mutations. These include things like exon 19 deletions and the L858R mutation, which are pretty common in NSCLC. You take it as a 250 mg tablet once a day.

You can choose to take it with or without food — it’s up to you. Each bottle holds 30 tablets. The idea is to stop EGFR signaling to keep cancer cells from growing, which could help patients do better.